Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.717
Filter
1.
Ghana Med J ; 58(3): 207-214, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39398086

ABSTRACT

Objective: The study aimed to assess antibiotic prescribing and use patterns at the Department of Surgery, Korle Bu Teaching Hospital. Design: A cross-sectional study design was employed in this study. Setting: The study was conducted at the Department of Surgery, Korle Bu Teaching Hospital. Participants: Forty-two prescribers out of 63 (67%) at the Department of Surgery responded to questionnaires. Over the study period, prescriptions and medical records of 1715 patients from the general surgery, neurosurgery, and urology units were reviewed. Main Outcome Measures: Percentage of prescriptions with antibiotics, percentage of prescribers using guidelines for antibiotic prescriptions, and percentage using culture and sensitivity to inform antibiotic prescriptions. Results: Of the 1715 prescriptions assessed, 75% (1294/1715) were from inpatients, and 45% (772/1715) included an antibiotic. Ciprofloxacin and metronidazole constituted 54% of antibiotic prescriptions from general surgery. Amoxicillin/clavulanic acid and ceftriaxone constituted 64.7% of antibiotic prescriptions from neurosurgery, and ceftriaxone and ciprofloxacin made up 37.7% of antibiotic prescriptions from urology. Microbiology testing was done for only 14.5% (9/62) of inpatients who received antibiotics for treatment. The choice of antibiotics was influenced mainly by doctors' previous experience (37/42, 88.1%). Conclusion: Antibiotics are widely used. About half of all prescriptions had antibiotics, with ciprofloxacin and metronidazole constituting more than half of antibiotic prescriptions from general surgery. Doctors mainly based their antibiotic prescriptions on previous experience and occasionally on microbiological investigations. Funding: None declared.


Subject(s)
Anti-Bacterial Agents , Hospitals, Teaching , Practice Patterns, Physicians' , Surgical Wound Infection , Tertiary Care Centers , Humans , Ghana , Cross-Sectional Studies , Anti-Bacterial Agents/therapeutic use , Male , Female , Hospitals, Teaching/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Adult , Middle Aged , Surgical Wound Infection/drug therapy , Surgical Wound Infection/epidemiology , Adolescent , Aged , Young Adult , Ciprofloxacin/therapeutic use , Child , Surveys and Questionnaires , Child, Preschool , Metronidazole/therapeutic use , Infant , Aged, 80 and over
2.
Pak J Pharm Sci ; 37(3): 695-703, 2024 May.
Article in English | MEDLINE | ID: mdl-39340860

ABSTRACT

Surgical Site Infection (SSI) has an enormous impact on patients' quality of life. SSIs further stresses on allocation of different health care resources and contribute significantly in terms of high cost of care. This was a prospective study carried out in tertiary care hospitals of Karachi, Pakistan, involving abdominal surgeries and few other surgeries, in patients having 20 years of age and above, were admitted from June 2016 to May 2017. Total number of 554 patients were included. Data was collected in all relevant areas including utilization pattern of antibiotics, cost in term of infected and uninfected patients, the duration of patient stay etc. Data analysis was performed using Statistical Package for the Social Sciences (SPSS) software. P value less than 0.005 was taken as significant. Single therapy of co amoxiclav or along with metronidazole and third generation cephalosporin were the most common prescribed antimicrobial groups. Amikacin most commonly used to treat post-surgical wound infection. Economic cost was high in terms of SSI patients. Duration of stay was found longer in infected patients. It can be concluded that SSI, may prolong length of hospitalization, cause morbidity, upsurge the health care cost and even may lead to mortality.


Subject(s)
Anti-Bacterial Agents , Length of Stay , Surgical Wound Infection , Tertiary Care Centers , Humans , Pakistan , Surgical Wound Infection/economics , Surgical Wound Infection/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/economics , Male , Female , Prospective Studies , Adult , Middle Aged , Young Adult , Aged , Surgery Department, Hospital/economics
3.
BMC Infect Dis ; 24(1): 990, 2024 Sep 17.
Article in English | MEDLINE | ID: mdl-39289609

ABSTRACT

BACKGROUND: Aspergillus spp. are rare causes of surgical site infections (SSIs). Specifically, Aspergillus section Nigri, commonly identified as Aspergillus niger through morphological findings, has infrequently been reported as an abdominal SSI pathogen. CASE PRESENTATION: An 86-year-old woman with a history of hypertension, chronic kidney disease, and atrial fibrillation who was taking 6 mg of prednisolone daily for rheumatoid arthritis was admitted to our hospital because of sudden abdominal pain. She was diagnosed with sigmoid colon perforation and underwent an open Hartmann operation on the day of admission. Subsequently, a superficial abdominal SSI was detected. Through analysis of the calmodulin gene, Aspergillus welwitschiae, which is classified within the Aspergillus section Nigri, was identified as the responsible pathogen. The minimum inhibitory concentration of voriconazole (VRCZ) was 2 mg/L. Surgical removal of the infected tissue and VRCZ administration was effectively used to treat the infection. CONCLUSIONS: Given the reported low susceptibility of Nigri section species to azoles, identification and drug susceptibility testing of these fungi are highly important.


Subject(s)
Antifungal Agents , Aspergillosis , Aspergillus , Surgical Wound Infection , Humans , Female , Aged, 80 and over , Aspergillus/isolation & purification , Aspergillus/genetics , Aspergillus/drug effects , Aspergillosis/microbiology , Aspergillosis/drug therapy , Aspergillosis/diagnosis , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Antifungal Agents/therapeutic use , Voriconazole/therapeutic use , Microbial Sensitivity Tests
4.
Surg Infect (Larchmt) ; 25(7): 492-498, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38973700

ABSTRACT

Introduction: Recently, antimicrobial resistance has received considerable attention. Broad-spectrum antimicrobial agents are recommended as the initial therapy for post-operative intra-abdominal infections. However, at our institution, we have adopted a tactic of initially treating post-operative intra-abdominal complications with relatively narrow-spectrum antimicrobial agents, such as second-generation cephalosporins. In the present study, we aimed to retrospectively analyze the use of antimicrobial agents and the resulting treatment outcomes in patients with intra-abdominal complications after gastrectomy at our facility. Methods: We conducted a retrospective observational study of patients treated with antibiotic agents for intra-abdominal infectious complications after gastrectomy between 2011 and 2021. We determined the proportion of "initial treatment failures" associated with the initial administration of antibiotic agents for post-operative intra-abdominal complications. Results: Post-operative intra-abdominal infections were observed in 29 patients. Broad-spectrum antimicrobial agents were not administered. We successfully treated 19 patients. Initial treatment failure was observed in 10 patients, of whom five experienced failure due to bacterial resistance to the initial antimicrobial agent. All 10 patients who experienced initial treatment failure were discharged after drainage procedures or other treatments. There were no deaths due to post-operative complications. Cefmetazole was used as the initial antimicrobial agent in 27 of the 29 patients. Conclusions: Considering that all patients with post-gastrectomy intra-abdominal infections were successfully treated using relatively narrow-spectrum antimicrobial agents, and initial treatment failure due to antimicrobial-resistant pathogens was 17.2%, the use of narrow-range antimicrobial agents for intra-abdominal infections after gastrectomy can be deemed appropriate.


Subject(s)
Gastrectomy , Intraabdominal Infections , Humans , Gastrectomy/adverse effects , Retrospective Studies , Intraabdominal Infections/drug therapy , Male , Female , Aged , Middle Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Treatment Outcome , Surgical Wound Infection/drug therapy , Adult , Feasibility Studies , Postoperative Complications/drug therapy , Postoperative Complications/microbiology
5.
J Infect Dev Ctries ; 18(7): 1132-1134, 2024 Jul 29.
Article in English | MEDLINE | ID: mdl-39078774

ABSTRACT

INTRODUCTION: Mediastinitis remains one of the most serious complications of cardiac surgery. The reported incidence is 1-4%, while the related mortality varies from 10-47%. CASE PRESENTATION: A patient with triple vessel disease (TVD) was hospitalized at our clinic for coronary artery bypass graft (CABG) surgery. The preoperative examination results were normal. We performed standard CABG under extracorporeal circulation. The patient had a favorable postoperative course. On the fifth postoperative day, the wound showed seropurulent drainage. The treatment of the patient's wound continued with open dressing, negative wound pressure device, debridement, minimal muscle plasticity, and total bilateral muscle pectoral flap plasticity. The infecting microorganism was identified as multidrug-resistant Acinetobacter baumani, and systemic antibiotic therapy was initiated. The patient had "per secundum closure" of the wound after all these efforts. The wound healed completely 2 months after discharge, and the patient was in good health. CONCLUSIONS: Mediastinitis is associated with high mortality and high financial and human costs. The occurrence of this high-risk complication can be prevented through constant vigilance at every step from admission to discharge.


Subject(s)
Acinetobacter Infections , Acinetobacter baumannii , Anti-Bacterial Agents , Drug Resistance, Multiple, Bacterial , Mediastinitis , Humans , Mediastinitis/microbiology , Mediastinitis/drug therapy , Acinetobacter baumannii/drug effects , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Male , Coronary Artery Bypass/adverse effects , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Middle Aged , Treatment Outcome , Aged
6.
Surg Infect (Larchmt) ; 25(6): 419-435, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38990709

ABSTRACT

Background: The Surgical Infection Society (SIS) published evidence-based guidelines for the management of intra-abdominal infection (IAI) in 1992, 2002, 2010, and 2017. Here, we present the most recent guideline update based on a systematic review of current literature. Methods: The writing group, including current and former members of the SIS Therapeutics and Guidelines Committee and other individuals with content or guideline expertise within the SIS, working with a professional librarian, performed a systematic review using PubMed/Medline, the Cochrane Library, Embase, and Web of Science from 2016 until February 2024. Keyword descriptors combined "surgical site infections" or "intra-abdominal infections" in adults limited to randomized controlled trials, systematic reviews, and meta-analyses. Additional relevant publications not in the initial search but identified during literature review were included. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) system was utilized to evaluate the evidence. The strength of each recommendation was rated strong (1) or weak (2). The quality of the evidence was rated high (A), moderate (B), or weak (C). The guideline contains new recommendations and updates to recommendations from previous IAI guideline versions. Final recommendations were developed by an iterative process. All writing group members voted to accept or reject each recommendation. Results: This updated evidence-based guideline contains recommendations from the SIS for the treatment of adult patients with IAI. Evidence-based recommendations were developed for antimicrobial agent selection, timing, route of administration, duration, and de-escalation; timing of source control; treatment of specific pathogens; treatment of specific intra-abdominal disease processes; and implementation of hospital-based antimicrobial agent stewardship programs. Summary: This document contains the most up-to-date recommendations from the SIS on the prevention and management of IAI in adult patients.


Subject(s)
Intraabdominal Infections , Humans , Intraabdominal Infections/drug therapy , Intraabdominal Infections/therapy , Surgical Wound Infection/prevention & control , Surgical Wound Infection/therapy , Surgical Wound Infection/drug therapy , Anti-Bacterial Agents/therapeutic use , Practice Guidelines as Topic
8.
J Antimicrob Chemother ; 79(8): 2062-2067, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-38958260

ABSTRACT

INTRODUCTION: Dalbavancin is an antibiotic active against most Gram-positive bacteria approved for acute bacterial skin and skin structure infections (ABSSSI). Owing to its long half-life, it is being increasingly used for other indications. PATIENTS AND METHODS: We present a case series of children and adolescents treated with dalbavancin for osteoarticular, catheter-related and other non-ABSSSI infections. RESULTS: Dalbavancin was prescribed to 15 patients. Six (40%) were female and median age at prescription was 11.9 (IQR 1.3-18.0) years. Most of them (12/15) had significant comorbidities. Patients presented mainly with deep surgical site infections, osteoarticular infections and central-line-associated bloodstream infections. The most common isolate was Staphylococcus aureus followed by Staphylococcus epidermidis. Major reasons to prescribe dalbavancin were to ensure compliance and patients' convenience. Two patients discontinued the drug due to adverse events possibly related to it. The rest of the patients completed the treatment with dalbavancin, with a median duration of 56 days (IQR 17.5, 115.5). All achieved complete resolution and present no relapse after a median follow-up of 9.9 months (IQR 4.8, 16.6). CONCLUSIONS: Dalbavancin was a safe, effective and convenient alternative in selected paediatric patients with complicated non-ABSSSI infections caused by Gram-positive bacteria.


Subject(s)
Anti-Bacterial Agents , Off-Label Use , Teicoplanin , Humans , Teicoplanin/analogs & derivatives , Teicoplanin/therapeutic use , Teicoplanin/adverse effects , Teicoplanin/administration & dosage , Female , Child , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/administration & dosage , Male , Child, Preschool , Infant , Adolescent , Treatment Outcome , Catheter-Related Infections/drug therapy , Catheter-Related Infections/microbiology , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Surgical Wound Infection/drug therapy , Surgical Wound Infection/microbiology
9.
Orthopedics ; 47(4): e211-e213, 2024.
Article in English | MEDLINE | ID: mdl-39038106

ABSTRACT

Ulnar-shortening osteotomy is a reliable solution to treat ulnar impaction syndrome, but it has a significant rate of nonunion as a known complication. Generally nonunion after the procedure is attributed to noninfectious causes. When infections happen, they follow the microbiological trends of nonunions elsewhere in the body. We present a case of ulnar-shortening osteotomy using an oblique-cut osteotomy system that resulted in septic nonunion. At the time of revision surgery, Cutibacterium acnes and Staphylococcus hominis were isolated from the osteotomy site. The patient was successfully treated using intravenous antibiotics and the two-stage Masquelet technique and eventually went on to bony union. As C acnes is rarely encountered in this context, this report highlights the need to consider all possible pathogens in the workup of a potentially septic nonunion. Surgeons should consider bacteria such as C acnes that require prolonged incubation for isolation from cultures, which may not be part of many institutions' usual protocol. [Orthopedics. 2024;47(4):e211-e213.].


Subject(s)
Anti-Bacterial Agents , Osteotomy , Humans , Osteotomy/adverse effects , Anti-Bacterial Agents/therapeutic use , Ulna/surgery , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/diagnosis , Fractures, Ununited/surgery , Fractures, Ununited/microbiology , Male , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Surgical Wound Infection/diagnosis , Surgical Wound Infection/etiology , Female , Reoperation , Adult , Propionibacteriaceae/isolation & purification
10.
J Mater Chem B ; 12(30): 7401-7419, 2024 Jul 31.
Article in English | MEDLINE | ID: mdl-38958038

ABSTRACT

Surgical site infection (SSI) caused by pathogenic bacteria leads to delayed wound healing and extended hospitalization. Inappropriate uses of antibiotics have caused a surge in SSI and common antibiotics are proving to be ineffective against SSI. Antimicrobial peptides (AMPs) can be a potential solution to prevent SSI because of their broad spectrum of antimicrobial activities. In this study, naturally sourced AMPs were studied along with microfibers, fabricated by a novel wet-spinning method using sodium alginate and polycaprolactone. Afterward, fibers were functionalized by the catechol groups of dopamine immobilizing nucleophilic AMPs on the surface. Conjugation between PCL and alginate resulted in fibers with smooth surfaces improving their mechanical strength via hydrogen bonds. Having an average diameter of 220 µm, the mechanical properties of the fiber complied with USP standards for suture size 3-0. Engineered microfibers were able to hinder the growth of Proteus spp., a pathogenic bacterium for at least 60 hours whereas antibiotic ceftazidime failed. When subjected to a linear incisional wound model study, accelerated healing was observed when the wound was closed using the engineered fiber compared to Vicryl. The microfibers promoted faster re-epithelialization compared to Vicryl proving their higher wound healing capacity.


Subject(s)
Alginates , Anti-Bacterial Agents , Catechols , Polyesters , Surgical Wound Infection , Alginates/chemistry , Alginates/pharmacology , Polyesters/chemistry , Polyesters/pharmacology , Surgical Wound Infection/prevention & control , Surgical Wound Infection/drug therapy , Catechols/chemistry , Catechols/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Animals , Antimicrobial Peptides/chemistry , Antimicrobial Peptides/pharmacology , Microbial Sensitivity Tests , Wound Healing/drug effects , Surface Properties
11.
Nanomedicine ; 60: 102757, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38889854

ABSTRACT

Surgical site infection (SSI) significantly affects patient recovery time, health outcomes and quality of life which is closely associated with the use of implants or mesh. Sutures are the most frequently used implants that play a significant role in the development of SSI. Studies have demonstrated that the administration of effective bactericidal and anti-inflammatory treatments can significantly decrease the incidence of SSI. To address this concern, a versatile suture was engineered by coating MoO3-X nanodots in this study. The incorporation of MoO3-X nanodots endowed the suture with desirable antibacterial and anti-inflammatory properties that were evaluated in in vitro and in vivo experiments. The results showed its remarkable ability to facilitate wound healing and prevent SSI through its dual action of combating bacterial infection and reducing inflammation. These findings highlight the promising potential of this multifunctional surgical suture as a versatile tool to promote better outcomes in surgical procedures.


Subject(s)
Anti-Bacterial Agents , Anti-Inflammatory Agents , Surgical Wound Infection , Sutures , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Surgical Wound Infection/prevention & control , Surgical Wound Infection/drug therapy , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Mice , Humans , Wound Healing/drug effects , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Nanoparticles/chemistry , Oxides/chemistry , Oxides/pharmacology , Male , Staphylococcus aureus/drug effects
12.
Int J Infect Dis ; 146: 107123, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38838847

ABSTRACT

This report details a rare case of surgical site infection (SSI) caused by Mycobacterium kansasii following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a 53-year-old patient with IgA-κ type multiple myeloma. After undergoing multiple chemotherapy regimens and two stem cell transplants, the patient developed an SSI 31-month post-transplantation, manifesting as an intracranial abscess at the site of a previous craniotomy. M. kansasii was isolated from the drainage fluid, marking this instance as a unique case in the literature of nontuberculous mycobacteria (NTM) infection post-allo-HSCT with such a delayed onset. The patient's treatment included targeted antimicrobial therapy based on susceptibility testing, resulting in eventual resolution of the infection, although the patient later succumbed to multiple myeloma relapse. This case underscores the critical need to consider NTM infections in the differential diagnosis of persistent fevers and SSIs in immunocompromised patients, particularly those with chronic graft-versus-host disease. It highlights the importance of early diagnostic and therapeutic interventions to manage these infections effectively. This report contributes to the limited but growing body of literature on NTM infections post-allo-HSCT and emphasizes the need for vigilance in monitoring postoperative patients, especially those with prolonged immunosuppression.


Subject(s)
Anti-Bacterial Agents , Hematopoietic Stem Cell Transplantation , Multiple Myeloma , Mycobacterium Infections, Nontuberculous , Mycobacterium kansasii , Surgical Wound Infection , Humans , Hematopoietic Stem Cell Transplantation/adverse effects , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium kansasii/isolation & purification , Middle Aged , Surgical Wound Infection/microbiology , Surgical Wound Infection/diagnosis , Surgical Wound Infection/drug therapy , Surgical Wound Infection/etiology , Male , Multiple Myeloma/therapy , Anti-Bacterial Agents/therapeutic use , Transplantation, Homologous/adverse effects , Immunocompromised Host , Fatal Outcome
13.
BMJ Case Rep ; 17(5)2024 May 15.
Article in English | MEDLINE | ID: mdl-38749526

ABSTRACT

We report the case of a female patient in her late 20s who visited the clinic with concerns about poor vision, redness, watering and a burning sensation in her left eye 2 weeks after undergoing a small incision lenticule extraction. She had no history of systemic illness or immunosuppressed status. On slit lamp examination, she was found to have corneal stromal infiltrates in the interface at multiple locations. Given the clinical diagnosis of microbial keratitis, corneal scraping of the interface infiltrate was performed and sent for microbiological examination revealing gram-positive, thin, beaded filaments that were acid-fast positive and later identified by growth in culture media as Nocardia species. This case was managed successfully with the use of topical amikacin and systemic trimethoprim-sulfamethoxazole with complete resolution of infection.


Subject(s)
Anti-Bacterial Agents , Eye Infections, Bacterial , Keratitis , Nocardia Infections , Humans , Female , Nocardia Infections/diagnosis , Nocardia Infections/drug therapy , Keratitis/microbiology , Keratitis/drug therapy , Keratitis/diagnosis , Keratitis/surgery , Anti-Bacterial Agents/therapeutic use , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/drug therapy , Amikacin/therapeutic use , Amikacin/administration & dosage , Adult , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Nocardia/isolation & purification , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Surgical Wound Infection/diagnosis
14.
Biomater Adv ; 161: 213896, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38795473

ABSTRACT

Surgical site infection (SSI) is a common issue post-surgery which often prolongs hospitalization and can lead to serious complications such as sternal wound infection following cardiac surgery via median sternotomy. Controlled release of suitable antibiotics could allow maximizing drug efficacy and safety, and therefore achieving a desired therapeutic response. In this study, we have developed a vancomycin laden PEGylated fibrinogen-polyethylene glycol diacrylate (PF-PEGDA) hydrogel system that can release vancomycin at a controlled and predictable rate to be applied in SSI prevention. Two configurations were developed to study effect of the hydrogel on drug release, namely, vancomycin laden hydrogel and vancomycin solution on top of blank hydrogel. The relationship between the rigidity of the hydrogel and drug diffusion was found to comply with a universal power law, i.e., softer hydrogels result in a greater diffusion coefficient hence faster release rate. Besides, vancomycin laden hydrogels exhibited burst release, whereas the vancomycin solution on top of blank hydrogels exhibited lag release. A mathematical model was developed to simulate vancomycin permeation through the hydrogels. The permeation of vancomycin can be predicted accurately by using the mathematical model, which provided a useful tool to customize drug loading, hydrogel thickness and stiffness for personalized medication to manage SSI. To evaluate the potential of hydrogels for bone healing applications in cardiovascular medicine, we performed a proof-of-concept median sternotomy in rabbits and applied the hydrogels. The hydrogel formulations accelerated the onset of osteo-genetic processes in rabbits, demonstrating its potential to be used in human.


Subject(s)
Anti-Bacterial Agents , Delayed-Action Preparations , Fibrinogen , Hydrogels , Polyethylene Glycols , Vancomycin , Vancomycin/administration & dosage , Vancomycin/chemistry , Vancomycin/pharmacokinetics , Polyethylene Glycols/chemistry , Fibrinogen/chemistry , Animals , Hydrogels/chemistry , Delayed-Action Preparations/pharmacokinetics , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacokinetics , Drug Liberation , Rabbits , Surgical Wound Infection/prevention & control , Surgical Wound Infection/drug therapy , Humans
15.
J Cardiothorac Surg ; 19(1): 289, 2024 May 14.
Article in English | MEDLINE | ID: mdl-38745239

ABSTRACT

INTRODUCTION: Deep sternal wound infection (DSWI) after midline sternotomy of cardiac surgery is a challenging complication that affects the outcome of surgery. This study aims to assess the clinical effectiveness of the antibiotic-loaded bone cement fixation technique combined with bilateral pectoralis major muscle flaps tension-free management in the treatment of DSWI. METHODS: We retrospectively analyzed 5 patients with DSWI who underwent antibiotic-loaded bone cement combined with bilateral pectoralis major muscle flaps for chest wall reconstruction after sternotomy for cardiac surgery in a tertiary hospital in China from January 2020 to December 2021. The clinical and follow-up data were retrospectively analyzed. RESULTS: All patients had no perioperative mortalities, no postoperative complications, 100% wound healing, and an average hospital stay length of 24 days. The follow-up periods were from 6 to 35 months (mean 19.6 months). None of the cases showed wound problems after initial reconstruction using antibiotic-loaded bone cement combined with bilateral pectoralis major muscle flaps. CONCLUSIONS: We report our successful treatment of DSWI, using antibiotic-loaded bone cement fixation technique combined with bilateral pectoralis major muscle flaps tension-free management. The clinical and follow-up results are favorable.


Subject(s)
Anti-Bacterial Agents , Bone Cements , Pectoralis Muscles , Sternotomy , Surgical Flaps , Surgical Wound Infection , Humans , Male , Sternotomy/adverse effects , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Retrospective Studies , Bone Cements/therapeutic use , Pectoralis Muscles/surgery , Middle Aged , Surgical Wound Infection/surgery , Surgical Wound Infection/drug therapy , Female , Aged , Cardiac Surgical Procedures/methods , Sternum/surgery , Plastic Surgery Procedures/methods
16.
Int J Nanomedicine ; 19: 3991-4005, 2024.
Article in English | MEDLINE | ID: mdl-38720939

ABSTRACT

Purpose: Surgical site infections pose a significant challenge for medical services. Systemic antibiotics may be insufficient in preventing bacterial biofilm development. With the local administration of antibiotics, it is easier to minimize possible complications, achieve drugs' higher concentration at the injured site, as well as provide their more sustained release. Therefore, the main objective of the proposed herein studies was the fabrication and characterization of innovative hydrogel-based composites for local vancomycin (VAN) therapy. Methods: Presented systems are composed of ionically gelled chitosan particles loaded with vancomycin, embedded into biomimetic collagen/chitosan/hyaluronic acid-based hydrogels crosslinked with genipin and freeze-dried to serve in a flake/disc-like form. VAN-loaded carriers were characterized for their size, stability, and encapsulation efficiency (EE) using dynamic light scattering technique, zeta potential measurements, and UV-Vis spectroscopy, respectively. The synthesized composites were tested in terms of their physicochemical and biological features. Results: Spherical structures with sizes of about 200 nm and encapsulation efficiencies reaching values of approximately 60% were obtained. It was found that the resulting particles exhibit stability over time. The antibacterial activity of the developed materials against Staphylococcus aureus was established. Moreover, in vitro cell culture study revealed that the surfaces of all prepared systems are biocompatible as they supported the proliferation and adhesion of the model MG-63 cells. In addition, we have demonstrated significantly prolonged VAN release while minimizing the initial burst effect for the composites compared to bare nanoparticles and verified their desired physicochemical features during swellability, and degradation experiments. Conclusion: It is expected that the developed herein system will enable direct delivery of the antibiotic at an exposed to infections surgical site, providing drugs sustained release and thus will reduce the risk of systemic toxicity. This strategy would both inhibit biofilm formation and accelerate the healing process.


Subject(s)
Anti-Bacterial Agents , Chitosan , Hydrogels , Staphylococcus aureus , Vancomycin , Vancomycin/chemistry , Vancomycin/pharmacology , Vancomycin/administration & dosage , Vancomycin/pharmacokinetics , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/administration & dosage , Hydrogels/chemistry , Hydrogels/pharmacology , Staphylococcus aureus/drug effects , Humans , Chitosan/chemistry , Hyaluronic Acid/chemistry , Hyaluronic Acid/pharmacology , Drug Carriers/chemistry , Collagen/chemistry , Collagen/pharmacology , Particle Size , Drug Liberation , Surgical Wound Infection/prevention & control , Surgical Wound Infection/drug therapy , Microbial Sensitivity Tests , Biofilms/drug effects
17.
Orbit ; 43(5): 559-565, 2024 Oct.
Article in English | MEDLINE | ID: mdl-38687955

ABSTRACT

PURPOSE: To describe the incidence and management of delayed infections following frontalis sling suspension with polybutylate-coated polyester suture (Ethibond). METHODS: Retrospective, interventional case series of 177 eyes of 150 patients, who underwent frontalis suspension surgery with Ethibond (Johnson and Johnson, USA), at L V Prasad Eye Institute, Hyderabad, India, between January 2016 and February 2022. Patients were assessed for chronic secondary sling infection, defined as infection/suture granuloma occurring beyond 6 weeks post-surgery. All patients received postoperative oral antibiotics. The clinical profile, microbiological evaluation, antibiotic sensitivity patterns, and management outcomes were analyzed. RESULTS: Delayed infection following Ethibond sling suspension was noted in 14 eyes of 13 patients (7.9%). Of these, eight cases (61.5%) were females. The average time interval from surgery to presentation was 7.5 months (range: 2.5 months to 2.5 years). Eleven eyes underwent sling removal. Of the three who received initial antibiotic course, two eventually needed sling removal. Microbiological evaluation was available in seven eyes (50%), with Staphylococcus aureus as the most common organism. Of the six positive cultures, five (83.3%) were resistant to fluoroquinolones (FQs). CONCLUSION: Frontalis suspension with Ethibond has an 8% incidence of delayed infections, with Staphylococcus aureus as the most common organism. The authors recommend early sling removal in all patients with infection and recommend consideration of an alternative material in the event of future revision surgery.


Subject(s)
Anti-Bacterial Agents , Blepharoptosis , Eye Infections, Bacterial , Polyesters , Surgical Wound Infection , Sutures , Humans , Female , Male , Retrospective Studies , Middle Aged , Adult , Blepharoptosis/surgery , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/drug therapy , Aged , Anti-Bacterial Agents/therapeutic use , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Suture Techniques , Incidence , Coated Materials, Biocompatible , Blepharoplasty/adverse effects
18.
Folia Microbiol (Praha) ; 69(3): 693-696, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38625660

ABSTRACT

Following the COVID-19 infection, the sternum dislocation and wound dehiscence resulted in an infection complicating the recovery of an immunosuppressed patient after bilateral lung transplantation. Anaerobic culture (96 h) of milky cloudy wound secretion resulted in the growth of pinpoint haemolytic colonies identified as Metamycoplasma hominis (formerly Mycoplasma hominis). The search for the endogenous source of the infection found the bacterium exclusively in the patient's sputum, making a possible link to donor lung M. hominis colonization. Unfortunately, the donor samples were no longer available. The wound infection was successfully treated with 17 days of clindamycin despite the continuous PCR detection of M. hominis in the sputum after the end of the treatment.


Subject(s)
Lung Transplantation , Mycoplasma Infections , Mycoplasma hominis , Surgical Wound Infection , Humans , Lung Transplantation/adverse effects , Surgical Wound Infection/microbiology , Surgical Wound Infection/drug therapy , Surgical Wound Infection/diagnosis , Mycoplasma hominis/genetics , Mycoplasma hominis/isolation & purification , Mycoplasma Infections/microbiology , Mycoplasma Infections/diagnosis , Mycoplasma Infections/drug therapy , Male , COVID-19/diagnosis , Anti-Bacterial Agents/therapeutic use , Sputum/microbiology , Middle Aged , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Immunocompromised Host , Clindamycin/therapeutic use
19.
Spine J ; 24(9): 1545-1552, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38679079

ABSTRACT

Cutibacterium acnes (C. acnes) previously named Propionibacterium acnes (P. acnes) has been increasingly recognized by spine surgeons as a cause of indolent postsurgical spinal infection. Patients infected with C. acnes may present with pseudarthrosis or nonspecific back pain. Currently, microbiological tissue cultures remain the gold standard in diagnosing C. acnes infection. Ongoing research into using genetic sequencing as a diagnostic method shows promising results and may be another future way of diagnosis. Optimized prophylaxis involves the use of targeted antibiotics, longer duration of antibiotic prophylaxis, antibacterial-coated spinal implants, and evidence-based sterile surgical techniques all of which decrease contamination. Antibiotics and implant replacement remain the mainstay of treatment, with longer durations of antibiotics proving to be more efficacious. Local guidelines must consider the surge of antimicrobial resistance worldwide when treating C. acnes.


Subject(s)
Anti-Bacterial Agents , Gram-Positive Bacterial Infections , Propionibacterium acnes , Surgical Wound Infection , Humans , Propionibacterium acnes/isolation & purification , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/therapy , Anti-Bacterial Agents/therapeutic use , Surgical Wound Infection/microbiology , Surgical Wound Infection/diagnosis , Surgical Wound Infection/therapy , Surgical Wound Infection/drug therapy , Spine/surgery
20.
ACS Appl Bio Mater ; 7(5): 3086-3095, 2024 05 20.
Article in English | MEDLINE | ID: mdl-38652779

ABSTRACT

Of the 27 million surgeries performed in the United States each year, a reported 2.6% result in a surgical site infection (SSI), and Staphylococci species are commonly the culprit. Alternative therapies, such as nitric oxide (NO)-releasing biomaterials, are being developed to address this issue. NO is a potent antimicrobial agent with several modes of action, including oxidative and nitrosative damage, disruption of bacterial membranes, and dispersion of biofilms. For targeted antibacterial effects, NO is delivered by exogenous donor molecules, like S-nitroso-N-acetylpenicillamine (SNAP). Herein, the impregnation of SNAP into poly(lactic-co-glycolic acid) (PLGA) for SSI prevention is reported for the first time. The NO-releasing PLGA copolymer is fabricated and characterized by donor molecule loading, leaching, and the amount remaining after ethylene oxide sterilization. The swelling ratio, water uptake, static water contact angle, and tensile strength are also investigated. Furthermore, its cytocompatibility is tested against 3T3 mouse fibroblast cells, and its antimicrobial efficacy is assessed against multiple Staphylococci strains. Overall, the NO-releasing PLGA copolymer holds promise as a suture material for eradicating surgical site infections caused by Staphylococci strains. SNAP impregnation affords robust antibacterial properties while maintaining the cytocompatibility and mechanical integrity.


Subject(s)
Anti-Bacterial Agents , Biocompatible Materials , Materials Testing , Nitric Oxide , Polylactic Acid-Polyglycolic Acid Copolymer , Surgical Wound Infection , Sutures , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Surgical Wound Infection/prevention & control , Surgical Wound Infection/drug therapy , Surgical Wound Infection/microbiology , Nitric Oxide/chemistry , Nitric Oxide/metabolism , Mice , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Animals , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Microbial Sensitivity Tests , Staphylococcal Infections/drug therapy , Staphylococcal Infections/prevention & control , Particle Size , Staphylococcus aureus/drug effects , Staphylococcus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL